Literature DB >> 9299960

Factor V Leiden and other coagulation factor mutations affecting thrombotic risk.

R M Bertina1.   

Abstract

Five genetic defects have been established as risk factors for venous thrombosis. Three are protein C, protein S, and antithrombin deficiencies, defects in the anticoagulant pathways of blood coagulation. Together they can be found in approximately 15% of families with inherited thrombophilia. Their laboratory diagnosis is hampered by the large genetic heterogeneity of these defects. The other two genetic risk factors, resistance to activated protein C associated with the factor V Leiden mutation and increased prothrombin associated with the prothrombin 20210 A allele, are much more prevalent and together can be found in 63% of the thrombophilia families. Because both defects are caused by a single mutation, DNA analysis is the basis of their laboratory diagnosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299960

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  Henoch-Schonlein purpura: polymorphisms in thrombophilia genes.

Authors:  Efrat Dagan; Riva Brik; Yiphtah Broza; Ruth Gershoni-Baruch
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

2.  Portal vein thrombosis.

Authors:  Hector Rodriguez-Luna; Hugo E Vargas
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

3.  Massive variceal bleeding secondary to splenic vein thrombosis successfully treated with splenic artery embolization: a case report.

Authors:  Daniel Paramythiotis; Theodossis S Papavramidis; Konstantinos Giavroglou; Stamatia Potsi; Fotis Girtovitis; Antonis Michalopoulos; Vassilis N Papadopoulos; John Prousalidis
Journal:  J Med Case Rep       Date:  2010-05-19

4.  Is there a link among thrombophilia factors and preeclampsia?

Authors:  Danyelle R A Rios; Patrícia Nessrala Alpoim; Lara Carvalho Godoi; Fernanda Santos Mendes; Bashir Lwaleed; Lirlândia P Sousa; Luiza O Perucci; Maria G Carvalho; Karina B G Borges; Luci M S Dusse
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

5.  Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.

Authors:  S Huber; K J McMaster; K V Voelkerding
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

6.  Influence of tissue factor polymorphisms (603A>G and 5466A>G) on plasma tissue factor levels and their impact on deep vein thrombosis risk in young Indian population.

Authors:  Kamal Kishor; Amit Sharma; Kanwaljeet Singh; Ravi Ranjan; Hareram Pandey; Ravi Kumar; Vineet Kumar Kamal; Pravas Mishra; Manoranjan Mahapatra; Renu Saxena
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

7.  Detection of genomic polymorphisms associated with venous thrombosis using the invader biplex assay.

Authors:  Madhumita Patnaik; Jeffrey S Dlott; Robert N Fontaine; M T Subbiah; Martin J Hessner; Kelly A Joyner; Marlies R Ledford; Eduardo C Lau; Cynthia Moehlenkamp; Jean Amos; Bailing Zhang; Thomas M Williams
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

8.  Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction.

Authors:  Mark W Gramling; Lea M Beaulieu; Frank C Church
Journal:  Exp Cell Res       Date:  2009-11-03       Impact factor: 3.905

9.  Cell adhesion molecule 1: a novel risk factor for venous thrombosis.

Authors:  Sandra J Hasstedt; Irene D Bezemer; Peter W Callas; Carla Y Vossen; Winifred Trotman; Robert P Hebbel; Christine Demers; Frits R Rosendaal; Edwin G Bovill
Journal:  Blood       Date:  2009-07-30       Impact factor: 22.113

10.  Prevalence of thrombophilic mutations in patients with unprovoked thromboembolic disease. A comparative analysis regarding arterial and venous disease.

Authors:  E Mandala; C Lafaras; C Tsioni; M Speletas; A Papageorgiou; D Kleta; T Dardavessis; G Ilonidis
Journal:  Hippokratia       Date:  2012-07       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.